ALRN   $3.77  1.34% Market Closed

Aileron Therapeutics Inc
Total Cash 21.92M
totalCashPerShare 1.012
EBITDA -25.40M
Total Debt 0.00
quickRatio 4.439
currentRatio 4.691
Total Revenue
debtToEquity
Revenue/Share
ROA -0.25856
ROE -0.44319
grossProfits
freeCashflow -12.07M
operatingCashflow -25.69M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 108.23M
forwardPE -2.1573033
floatShares 19.42M
sharesOutstanding 21.67M
sharesShort 255.55K
sharesShortPriorMonth 257.06K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.32%
Short Ratio help_outline 2.69%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.59
Price To Book help_outline 1.48
earningsQuarterlyGrowth
netIncomeToCommon -25.22M
trailingEps -3.10%
forwardEps -1.78%
enterpriseToEbitda -4.26
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.41 3Q 2024
institutionsCount 34
lastUpdated Nov. 7, 2024, 3:09 a.m.